{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:57:45Z","timestamp":1791899865508,"version":"4.3.4"},"reference-count":75,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":2111,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1038\/labinvest.2016.153","type":"journal-article","created":{"date-parts":[[2017,1,23]],"date-time":"2017-01-23T08:42:26Z","timestamp":1485160946000},"page":"370-382","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Reversal of maladaptive fibrosis and compromised ventricular function in the pressure overloaded heart by a caveolin-1 surrogate peptide"],"prefix":"10.1016","volume":"97","author":[{"given":"Dorea","family":"Pleasant-Jenkins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Reese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panneerselvem","family":"Chinnakkannu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harinath","family":"Kasiganesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Tourkina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhandapani","family":"Kuppuswamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/labinvest.2016.153_bib1","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s00109-015-1314-y","article-title":"Cardiac fibroblasts: from development to heart failure","volume":"93","author":"Moore-Morris","year":"2015","journal-title":"J Mol Med"},{"key":"10.1038\/labinvest.2016.153_bib2","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1161\/CIRCRESAHA.115.303794","article-title":"Developmental heterogeneity of cardiac fibroblasts does not predict pathological proliferation and activation","volume":"115","author":"Ali","year":"2014","journal-title":"Circ Res"},{"key":"10.1038\/labinvest.2016.153_bib3","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1172\/JCI74783","article-title":"Resident fibroblast lineages mediate pressure overload-induced cardiac fibrosis","volume":"124","author":"Moore-Morris","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1038\/labinvest.2016.153_bib4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1755-1536-5-15","article-title":"Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease","volume":"5","author":"Fan","year":"2012","journal-title":"Fibrogenesis Tissue Repair"},{"key":"10.1038\/labinvest.2016.153_bib5","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/jcp.22322","article-title":"The origin of fibroblasts and mechanism of cardiac fibrosis","volume":"225","author":"Krenning","year":"2010","journal-title":"J Cell Physiol"},{"key":"10.1038\/labinvest.2016.153_bib6","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s12265-012-9402-7","article-title":"Origin of developmental precursors dictates the pathophysiologic role of cardiac fibroblasts","volume":"5","author":"Crawford","year":"2012","journal-title":"J Cardiovasc Transl Res"},{"key":"10.1038\/labinvest.2016.153_bib7","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.ajpath.2012.02.004","article-title":"Recent developments in myofibroblast biology: paradigms for connective tissue remodeling","volume":"180","author":"Hinz","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1038\/labinvest.2016.153_bib8","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.yjmcc.2010.05.005","article-title":"Monocytic fibroblast precursors mediate fibrosis in angiotensin-II-induced cardiac hypertrophy","volume":"49","author":"Haudek","year":"2010","journal-title":"J Mol Cell Cardiol"},{"key":"10.1038\/labinvest.2016.153_bib9","doi-asserted-by":"crossref","first-page":"18284","DOI":"10.1073\/pnas.0608799103","article-title":"Bone marrow-derived fibroblast precursors mediate ischemic cardiomyopathy in mice","volume":"103","author":"Haudek","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/labinvest.2016.153_bib10","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.cardiores.2006.06.013","article-title":"Bone marrow-derived cells contribute to infarct remodelling","volume":"71","author":"Mollmann","year":"2006","journal-title":"Cardiovasc Res"},{"key":"10.1038\/labinvest.2016.153_bib11","doi-asserted-by":"crossref","first-page":"H538","DOI":"10.1152\/ajpheart.01114.2010","article-title":"CCR2 mediates the uptake of bone marrow-derived fibroblast precursors in angiotensin II-induced cardiac fibrosis","volume":"301","author":"Xu","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1038\/labinvest.2016.153_bib12","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1097\/HJH.0b013e32835639bb","article-title":"Elevated circulating fibrocyte levels in patients with hypertensive heart disease","volume":"30","author":"Keeley","year":"2012","journal-title":"J Hypertens"},{"key":"10.1038\/labinvest.2016.153_bib13","doi-asserted-by":"crossref","first-page":"13879","DOI":"10.1074\/jbc.M412551200","article-title":"Opposing effects of protein kinase Calpha and protein kinase Cepsilon on collagen expression by human lung fibroblasts are mediated via MEK\/ERK and caveolin-1 signaling","volume":"280","author":"Tourkina","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1038\/labinvest.2016.153_bib14","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1084\/jem.20061536","article-title":"Caveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosis","volume":"203","author":"Wang","year":"2006","journal-title":"J Exp Med"},{"key":"10.1038\/labinvest.2016.153_bib15","doi-asserted-by":"crossref","first-page":"6525","DOI":"10.1074\/jbc.272.10.6525","article-title":"Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins","volume":"272","author":"Couet","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1038\/labinvest.2016.153_bib16","doi-asserted-by":"crossref","first-page":"33416","DOI":"10.1074\/jbc.272.52.33416","article-title":"Caveolin interaction with protein kinase C. Isoenzyme-dependent regulation of kinase activity by the caveolin scaffolding domain peptide","volume":"272","author":"Oka","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1038\/labinvest.2016.153_bib17","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1161\/01.RES.84.9.980","article-title":"Activated protein kinase C isoforms target to cardiomyocyte caveolae: stimulation of local protein phosphorylation","volume":"84","author":"Rybin","year":"1999","journal-title":"Circ Res"},{"key":"10.1038\/labinvest.2016.153_bib18","doi-asserted-by":"crossref","first-page":"6727","DOI":"10.1074\/jbc.M008340200","article-title":"Caveolin-1 regulates transforming growth factor (TGF)-beta\/SMAD signaling through an interaction with the TGF-beta type I receptor","volume":"276","author":"Razani","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1038\/labinvest.2016.153_bib19","doi-asserted-by":"crossref","first-page":"5760","DOI":"10.1074\/jbc.M701572200","article-title":"Down-regulation of caveolin-1, an inhibitor of transforming growth factor-beta signaling, in acute allergen-induced airway remodeling","volume":"283","author":"Le Saux","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1038\/labinvest.2016.153_bib20","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1073\/pnas.0407224102","article-title":"Dissecting the molecular control of endothelial NO synthase by caveolin-1 using cell-permeable peptides","volume":"102","author":"Bernatchez","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/labinvest.2016.153_bib21","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1126\/science.1062688","article-title":"Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disruptedmice","volume":"293","author":"Drab","year":"2001","journal-title":"Science"},{"key":"10.1038\/labinvest.2016.153_bib22","doi-asserted-by":"crossref","first-page":"38121","DOI":"10.1074\/jbc.M105408200","article-title":"Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities","volume":"276","author":"Razani","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1038\/labinvest.2016.153_bib23","doi-asserted-by":"crossref","first-page":"C457","DOI":"10.1152\/ajpcell.00380.2002","article-title":"Caveolin-1 null mice develop cardiac hypertrophy with hyperactivation of p42\/44 MAP kinase in cardiac fibroblasts","volume":"284","author":"Cohen","year":"2003","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1038\/labinvest.2016.153_bib24","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1002\/art.23791","article-title":"Decreased expression of caveolin 1 in patients with systemic sclerosis: crucial role in the pathogenesis of tissue fibrosis","volume":"58","author":"Del Galdo","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1038\/labinvest.2016.153_bib25","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1136\/ard.2009.117580","article-title":"Caveolin-1 regulates leucocyte behaviour in fibrotic lung disease","volume":"69","author":"Tourkina","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1038\/labinvest.2016.153_bib26","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s004180050200","article-title":"Loss of caveolin expression in type I pneumocytes as an indicator of subcellular alterations during lung fibrogenesis","volume":"109","author":"Kasper","year":"1998","journal-title":"Histochem Cell Biol"},{"key":"10.1038\/labinvest.2016.153_bib27","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3389\/fphar.2014.00140","article-title":"Caveolin-1 regulates chemokine receptor 5-mediated contribution of bone marrow-derived cells to dermal fibrosis","volume":"5","author":"Lee","year":"2014","journal-title":"Front Pharmacol"},{"key":"10.1038\/labinvest.2016.153_bib28","doi-asserted-by":"crossref","first-page":"L736","DOI":"10.1152\/ajplung.00210.2013","article-title":"Bleomycin delivery by osmotic minipump: similarity to human scleroderma interstitial lung disease","volume":"306","author":"Lee","year":"2014","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1038\/labinvest.2016.153_bib29","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1755-1536-4-15","article-title":"Altered monocyte and fibrocyte phenotype and function in scleroderma interstitial lung disease: reversal by caveolin-1 scaffolding domain peptide","volume":"4","author":"Tourkina","year":"2011","journal-title":"Fibrogenesis Tissue Repair"},{"key":"10.1038\/labinvest.2016.153_bib30","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1002\/art.38572","article-title":"Caveolin-1 deficiency may predispose African Americans to systemic sclerosis-related interstitial lung disease","volume":"66","author":"Reese","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1038\/labinvest.2016.153_bib31","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.matbio.2011.05.003","article-title":"Caveolin-1 modulates TGF-beta1 signaling in cardiac remodeling","volume":"30","author":"Miyasato","year":"2011","journal-title":"Matrix Biol"},{"key":"10.1038\/labinvest.2016.153_bib32","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.yjmcc.2014.07.020","article-title":"Caveolin-1 deletion exacerbates cardiac interstitial fibrosis by promoting M2 macrophage activation in mice after myocardial infarction","volume":"76","author":"Shivshankar","year":"2014","journal-title":"J Mol Cell Cardiol"},{"key":"10.1038\/labinvest.2016.153_bib33","doi-asserted-by":"crossref","first-page":"e85144","DOI":"10.1371\/journal.pone.0085144","article-title":"Role of caveolin-1 in atrial fibrillation as an anti-fibrotic signaling molecule in human atrial fibroblasts","volume":"9","author":"Yi","year":"2014","journal-title":"PLoS One"},{"key":"10.1038\/labinvest.2016.153_bib34","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.4161\/cbt.8.23.10138","article-title":"Caveolin-1 regulates VEGF-stimulated angiogenic activities in prostate cancer and endothelial cells","volume":"8","author":"Tahir","year":"2009","journal-title":"Cancer Biol Ther"},{"key":"10.1038\/labinvest.2016.153_bib35","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1158\/0008-5472.CAN-07-2668","article-title":"Tumor cell-secreted caveolin-1 has proangiogenic activities in prostate cancer","volume":"68","author":"Tahir","year":"2008","journal-title":"Cancer Res"},{"key":"10.1038\/labinvest.2016.153_bib36","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1038\/82176","article-title":"In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation","volume":"6","author":"Bucci","year":"2000","journal-title":"Nat Med"},{"key":"10.1038\/labinvest.2016.153_bib37","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13069-015-0028-7","article-title":"Enhanced chemokine-receptor expression, function, and signaling in healthy African American and scleroderma-patient monocytes are regulated by caveolin-1","volume":"8","author":"Lee","year":"2015","journal-title":"Fibrogenesis Tissue Repair"},{"key":"10.1038\/labinvest.2016.153_bib38","doi-asserted-by":"crossref","first-page":"L843","DOI":"10.1152\/ajplung.00295.2007","article-title":"Antifibrotic properties of caveolin-1 scaffolding domain in vitroin vivo","volume":"294","author":"Tourkina","year":"2008","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1038\/labinvest.2016.153_bib39","doi-asserted-by":"crossref","first-page":"e45076","DOI":"10.1371\/journal.pone.0045076","article-title":"beta3 integrin in cardiac fibroblast is critical for extracellular matrix accumulation during pressure overload hypertrophy in mouse","volume":"7","author":"Balasubramanian","year":"2012","journal-title":"PLoS One"},{"key":"10.1038\/labinvest.2016.153_bib40","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/FJC.0000000000000322","article-title":"mTOR complexes repress hypertrophic agonist-stimulated expression of connective tissue growth factor in adult cardiac muscle cells","volume":"67","author":"Sundararaj","year":"2016","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1038\/labinvest.2016.153_bib41","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1096\/fj.08-127480","article-title":"Beta3 integrin-mediated ubiquitination activates survival signaling during myocardial hypertrophy","volume":"23","author":"Johnston","year":"2009","journal-title":"FASEB J"},{"key":"10.1038\/labinvest.2016.153_bib42","doi-asserted-by":"crossref","first-page":"e0140273","DOI":"10.1371\/journal.pone.0140273","article-title":"Dasatinib attenuates pressure overload induced cardiac fibrosis in a murine transverse aortic constriction model","volume":"10","author":"Balasubramanian","year":"2015","journal-title":"PLoS One"},{"key":"10.1038\/labinvest.2016.153_bib43","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0022-2828(03)00112-3","article-title":"Focal complex formation in adult cardiomyocytes is accompanied by the activation of beta3 integrin and c-Src","volume":"35","author":"Willey","year":"2003","journal-title":"J Mol Cell Cardiol"},{"key":"10.1038\/labinvest.2016.153_bib44","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.tem.2009.03.005","article-title":"eNOS, metabolic syndrome and cardiovascular disease","volume":"20","author":"Huang","year":"2009","journal-title":"Trends Endocrinol Metab"},{"key":"10.1038\/labinvest.2016.153_bib45","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.4049\/jimmunol.179.6.4035","article-title":"Reduction of bleomycin-induced pulmonary fibrosis by serum amyloid P","volume":"179","author":"Pilling","year":"2007","journal-title":"J Immunol"},{"key":"10.1038\/labinvest.2016.153_bib46","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/01.CIR.91.1.161","article-title":"Myocardial fibrosis and stiffness with hypertrophy and heart failure in the spontaneously hypertensive rat","volume":"91","author":"Conrad","year":"1995","journal-title":"Circulation"},{"key":"10.1038\/labinvest.2016.153_bib47","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1146\/annurev.med.55.091902.104417","article-title":"Left ventricular diastolic dysfunction and diastolic heart failure","volume":"55","author":"Gaasch","year":"2004","journal-title":"Annu Rev Med"},{"key":"10.1038\/labinvest.2016.153_bib48","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s11886-009-0061-5","article-title":"Hypertension and diastolic heart failure","volume":"11","author":"Gradman","year":"2009","journal-title":"Curr Cardiol Rep"},{"key":"10.1038\/labinvest.2016.153_bib49","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0735-1097(92)90130-F","article-title":"Remodeling and reparation of the cardiovascular system","volume":"20","author":"Weber","year":"1992","journal-title":"J Am Coll Cardiol"},{"key":"10.1038\/labinvest.2016.153_bib50","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1161\/CIRCULATIONAHA.114.013215","article-title":"Myocardial stiffness in patients with heart failure and a preserved ejection fraction: contributions of collagen and titin","volume":"131","author":"Zile","year":"2015","journal-title":"Circulation"},{"key":"10.1038\/labinvest.2016.153_bib51","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1084\/jem.20062340","article-title":"Reexpression of caveolin-1 in endothelium rescues the vascular, cardiac, and pulmonary defects in global caveolin-1 knockout mice","volume":"204","author":"Murata","year":"2007","journal-title":"J Exp Med"},{"key":"10.1038\/labinvest.2016.153_bib52","first-page":"66","article-title":"Caveolin and caveolae in age associated cardiovascular disease","volume":"10","author":"Fridolfsson","year":"2013","journal-title":"J Geriatr Cardiol"},{"key":"10.1038\/labinvest.2016.153_bib53","doi-asserted-by":"crossref","first-page":"H1274","DOI":"10.1152\/ajpheart.01173.2010","article-title":"Caveolin-1 deficiency exacerbates cardiac dysfunction and reduces survival in mice with myocardial infarction","volume":"300","author":"Jasmin","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1038\/labinvest.2016.153_bib54","doi-asserted-by":"crossref","first-page":"29182","DOI":"10.1074\/jbc.271.46.29182","article-title":"Src tyrosine kinases, Galpha subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin. Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases","volume":"271","author":"Li","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1038\/labinvest.2016.153_bib55","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1146\/annurev.pharmtox.48.121506.124841","article-title":"Caveolae as organizers of pharmacologically relevant signal transduction molecules","volume":"48","author":"Patel","year":"2008","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1038\/labinvest.2016.153_bib56","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.yjmcc.2015.10.001","article-title":"Normal and high eNOS levels are detrimental in both mild and severe cardiac pressure-overload","volume":"88","author":"van Deel","year":"2015","journal-title":"J Mol Cell Cardiol"},{"key":"10.1038\/labinvest.2016.153_bib57","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1073\/pnas.87.4.1620","article-title":"Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide","volume":"87","author":"Beckman","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/labinvest.2016.153_bib58","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.abb.2008.12.020","article-title":"The formation of peroxynitrite in the applied physiology of mitochondrial nitric oxide","volume":"484","author":"Poderoso","year":"2009","journal-title":"Arch Biochem Biophys"},{"key":"10.1038\/labinvest.2016.153_bib59","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/cvr\/cvn080","article-title":"Control of blood pressure variability in caveolin-1-deficient mice: role of nitric oxide identified in vivo through spectral analysis","volume":"79","author":"Desjardins","year":"2008","journal-title":"Cardiovasc Res"},{"key":"10.1038\/labinvest.2016.153_bib60","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1535-6108(03)00168-5","article-title":"Selective inhibition of tumor microvascular permeability by cavtratin blocks tumor progression in mice","volume":"4","author":"Gratton","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1038\/labinvest.2016.153_bib61","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.exphem.2010.03.004","article-title":"Fibrocytes in health and disease","volume":"38","author":"Herzog","year":"2010","journal-title":"Exp Hematol"},{"key":"10.1038\/labinvest.2016.153_bib62","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1160\/TH08-11-0726","article-title":"The role of circulating mesenchymal progenitor cells (fibrocytes) in the pathogenesis of fibrotic disorders","volume":"101","author":"Keeley","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1038\/labinvest.2016.153_bib63","doi-asserted-by":"crossref","first-page":"e7475","DOI":"10.1371\/journal.pone.0007475","article-title":"Identification of markers that distinguish monocyte-derived fibrocytes from monocytes, macrophages, and fibroblasts","volume":"4","author":"Pilling","year":"2009","journal-title":"PLoS One"},{"key":"10.1038\/labinvest.2016.153_bib64","doi-asserted-by":"crossref","first-page":"419","DOI":"10.4049\/jimmunol.160.1.419","article-title":"Regulated production of type I collagen and inflammatory cytokines by peripheral blood fibrocytes","volume":"160","author":"Chesney","year":"1998","journal-title":"J Immunol"},{"key":"10.1038\/labinvest.2016.153_bib65","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1096\/fj.01-0049com","article-title":"Fibrocytes induce an angiogenic phenotype in cultured endothelial cells and promote angiogenesis in vivo","volume":"15","author":"Hartlapp","year":"2001","journal-title":"FASEB J"},{"key":"10.1038\/labinvest.2016.153_bib66","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/labinvest.2010.73","article-title":"Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype","volume":"90","author":"Mathai","year":"2010","journal-title":"Lab Invest"},{"key":"10.1038\/labinvest.2016.153_bib67","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1055\/s-0030-1250658","article-title":"Heat shock protein 47 (HSP47) antisense oligonucleotides reduce cardiac remodeling and improve cardiac function in a rat model of myocardial infarction","volume":"59","author":"Hagiwara","year":"2011","journal-title":"Thorac Cardiovasc Surg"},{"key":"10.1038\/labinvest.2016.153_bib68","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.yjmcc.2013.10.017","article-title":"Adverse fibrosis in the aging heart depends on signaling between myeloid and mesenchymal cells; role of inflammatory fibroblasts","volume":"70","author":"Cieslik","year":"2014","journal-title":"J Mol Cell Cardiol"},{"key":"10.1038\/labinvest.2016.153_bib69","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1096\/fj.14-268136","article-title":"Mesenchymal stem cell-derived inflammatory fibroblasts promote monocyte transition into myeloid fibroblasts via an IL-6-dependent mechanism in the aging mouse heart","volume":"29","author":"Cieslik","year":"2015","journal-title":"FASEB J"},{"key":"10.1038\/labinvest.2016.153_bib70","doi-asserted-by":"crossref","first-page":"10179","DOI":"10.1073\/pnas.0804910105","article-title":"Fc receptor engagement mediates differentiation of cardiac fibroblast precursor cells","volume":"105","author":"Haudek","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/labinvest.2016.153_bib71","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1016\/j.jacc.2015.03.520","article-title":"Interacting resident epicardium-derived fibroblasts and recruited bone marrow cells form myocardial infarction scar","volume":"65","author":"Ruiz-Villalba","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1038\/labinvest.2016.153_bib72","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/path.2281","article-title":"Bone marrow-derived myofibroblasts contribute functionally to scar formation after myocardial infarction","volume":"214","author":"van Amerongen","year":"2008","journal-title":"J Pathol"},{"key":"10.1038\/labinvest.2016.153_bib73","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1196\/annals.1380.003","article-title":"Recruitment of new cells into the postnatal heart: potential modification of phenotype by periostin","volume":"1080","author":"Visconti","year":"2006","journal-title":"Ann NY Acad Sci"},{"key":"10.1038\/labinvest.2016.153_bib74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yjmcc.2015.12.031","article-title":"Origins of cardiac fibroblasts","volume":"91","author":"Moore-Morris","year":"2016","journal-title":"J Mol Cell Cardiol"},{"key":"10.1038\/labinvest.2016.153_bib75","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3389\/fphar.2014.00141","article-title":"Fibrocytes in the fibrotic lung: altered phenotype detected by flow cytometry","volume":"5","author":"Reese","year":"2014","journal-title":"Front Pharmacol"}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/labinvest2016153.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/labinvest2016153","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722011631?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722011631?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/labinvest2016153.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T19:35:45Z","timestamp":1758396945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0023683722011631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":75,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0023683722011631"],"URL":"https:\/\/doi.org\/10.1038\/labinvest.2016.153","relation":{},"ISSN":["0023-6837"],"issn-type":[{"value":"0023-6837","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reversal of maladaptive fibrosis and compromised ventricular function in the pressure overloaded heart by a caveolin-1 surrogate peptide","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/labinvest.2016.153","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}